Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

Personalised vaccines to treat skin cancer show promise in small studies

Personalised vaccines have been used to successfully treat melanoma (skin cancer) patients in two small studies.

Cancer Research UK responds to Fundraising Preference Service announcement

Cancer Research UK responds to the news that the Fundraising Preference Service will enable people to opt out of charity communications

Greater access to genetic testing needed for cancer diagnosis and treatment

Cancer patients should have routine access to genetic testing to improve diagnosis and treatment, according to England’s chief medical officer.

News digest – Frozen needles, a smokefree UK, microbubbles and… breaking cancer’s ‘legs’?

Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.

The UK is 10 years smoke-free and there’s more at stake than just clean-smelling clothes

It’s 10 years since a trip to your local would leave you smelling like an ashtray – find out how our health has changed, and what more we need to do.

Large health inequalities across England revealed

There are stark differences in how long people in different parts of England can expect to live a healthy life, according to a new report.

More than a quarter of women missing smear tests are unaware they exist

More than a quarter (28 per cent) of women who are overdue for a smear test don’t know about the cervical screening programme.

Why you need to ‘opt in’ to keep hearing from Cancer Research UK

Cancer Research UK is becoming an 'opt-in' charity - but what exactly does that mean for you and the way we work?

British smokers down by 1.9million since the ban

Ten years after the smoking ban, new figures from Cancer Research UK reveal there are 1.9 million* fewer smokers in Britain.

CRT’s Discovery Laboratories extends alliance with Merck to develop new cancer drugs

Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway.

Pages